Option Care Health is the nation's largest independent provider of home and alternate site infusion services. With over 5,000 teammates, including approximately 2,900 clinicians, the company works compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through its clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and teammates.
Company profile
Ticker
OPCH
Exchange
Website
CEO
John Rademacher
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Aveanna Healthcare • Enhabit • Signify Health • Chemed • Apria • Amedisys • LHC • Addus HomeCare • Natur International • AdaptHealth ...
Former names
BioScrip, Inc., MIM CORP
SEC CIK
Corporate docs
Subsidiaries
Applied Health Care, LLC • BioScrip Infusion Services, Inc. • BioScrip Infusion Services, LLC • BioScrip PBM Services, LLC • BioScrip Pharmacy (NY), Inc. • BioScrip Pharmacy Services, Inc. • CHI Holding Corp. • Chronimed, LLC • CHS Holdings, Inc. • Clinical Holdings, Inc. ...
IRS number
50489664
OPCH stock data
Analyst ratings and price targets
Latest filings (excl ownership)
S-4
Registration of securities issued in business combination transactions
5 Jun 23
425
Business combination disclosure
25 May 23
8-K
Submission of Matters to a Vote of Security Holders
19 May 23
425
Business combination disclosure
17 May 23
425
Business combination disclosure
15 May 23
425
Business combination disclosure
15 May 23
425
Business combination disclosure
9 May 23
425
Business combination disclosure
4 May 23
10-Q
2023 Q1
Quarterly report
4 May 23
425
Business combination disclosure
4 May 23
Transcripts
OPCH
Earnings call transcript
2022 Q3
27 Oct 22
OPCH
Earnings call transcript
2022 Q2
27 Jul 22
OPCH
Earnings call transcript
2022 Q1
28 Apr 22
OPCH
Earnings call transcript
2021 Q4
23 Feb 22
OPCH
Earnings call transcript
2022 Q4
23 Feb 22
OPCH
Earnings call transcript
2021 Q3
6 Nov 21
OPCH
Earnings call transcript
2021 Q2
3 Aug 21
OPCH
Earnings call transcript
2021 Q1
8 May 21
OPCH
Earnings call transcript
2020 Q4
11 Mar 21
OPCH
Earnings call transcript
2020 Q3
3 Nov 20
Latest ownership filings
Financial summary
| Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Institutional ownership, Q1 2023
95.5% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 278 |
| Opened positions | 30 |
| Closed positions | 40 |
| Increased positions | 140 |
| Reduced positions | 83 |
| 13F shares | Current |
|---|---|
| Total value | 5.03 tn |
| Total shares | 171.76 mm |
| Total puts | 4.50 k |
| Total calls | 76.30 k |
| Total put/call ratio | 0.1 |
| Largest owners | Shares | Value |
|---|---|---|
| BLK Blackrock | 21.44 mm | $681.28 bn |
| Vanguard | 16.51 mm | $524.59 bn |
| FMR | 12.57 mm | $399.47 bn |
| WBA Walgreens Boots Alliance | 10.77 mm | $337.05 mm |
| STT State Street | 5.44 mm | $172.98 bn |
| T. Rowe Price Investment Management | 5.27 mm | $166.02 bn |
| Citadel Advisors | 5.04 mm | $160.10 bn |
| Point72 Asset Management | 4.27 mm | $135.62 bn |
| Ubs Global Asset Management Americas | 3.78 mm | $120.08 bn |
| Park West Asset Management | 3.56 mm | $113.07 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 19 May 23 | Collin Smyser | Common Stock | Payment of exercise | Dispose F | No | No | 28.59 | 238 | 6.80 k | 16,385 |
| 19 May 23 | Collin Smyser | Common Stock | Option exercise | Acquire M | No | No | 0 | 812 | 0.00 | 16,623 |
| 19 May 23 | Collin Smyser | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 812 | 0.00 | 2,436 |
| 17 May 23 | Betten Elizabeth Quadros | Common Stock | Grant | Acquire A | No | No | 0 | 7,185 | 0.00 | 63,545 |
| 17 May 23 | Sullivan Timothy P | Common Stock | Grant | Acquire A | No | No | 0 | 7,008 | 0.00 | 62,738 |
| 17 May 23 | Pate R Carter | Common Stock | Grant | Acquire A | No | No | 0 | 9,117 | 0.00 | 104,647 |
| 17 May 23 | Harry M Jansen Kraemer JR | Common Stock | Grant | Acquire A | No | No | 0 | 12,630 | 0.00 | 179,528 |
News
Optum's Decision To Target Amedisys Is Intriguing, Says Analyst
5 Jun 23
Why Shares Of Amedisys Inc Are Rising
5 Jun 23
Option Care Health Issues Statement On Optum Proposal For Amedisys
5 Jun 23
10 Health Care Stocks With Whale Alerts In Today's Session
25 May 23
Option Care Health Selected By Krystal Biotech As Part Of A Limited Distribution Specialty Pharmacy Network For VYJUVEK
23 May 23
Press releases
Option Care Health Reiterates Value Creation Opportunity of its Previously Announced Definitive Merger Agreement with Amedisys
5 Jun 23
Amedisys Announces Receipt of Unsolicited Proposal From Optum
5 Jun 23
Option Care Health Selected by Krystal Biotech as Part of a Limited Distribution Specialty Pharmacy Network for VYJUVEK™
23 May 23
Option Care Health to Participate in Upcoming Investor Conferences
18 May 23
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ISEE, OPCH, AMED
14 May 23